20 LATEST RESOURCES (728 INDEXED)
Impacts of Metabolic Disruption, Body Mass Index and Inflammation on Cognitive Function in Post-COVID-19 Condition: A Randomized Controlled Trial on Vortioxetine · February 2024
Articles
Annals of General Psychiatry
Optimizing Warfarin Dosing for Patients with Atrial Fibrillation Using Machine Learning · February 2024
Articles
Scientific Reports
Factors Associated with Frequent Buprenorphine / Naloxone Initiation in a National Survey of Canadian Emergency Physicians · February 2024
Articles
PLOS ONE
Ketamine for Adults with Treatment-Resistant Depression or Posttraumatic Stress Disorder: A 2023 Update · January 2024
Publications (Books-Reports)
Canadian Agency for Drugs and Technologies in Health
Use of Ketamine for Treatment Resistant Depression: Updated Review of Literature and Practical Applications to a Community Ketamine Program in Edmonton, Alberta, Canada · January 2024
Articles
Frontiers in Psychiatry
Evaluation of Machine Learning Approaches for Predicting Warfarin Discharge Dose in Cardiac Surgery Patients: Retrospective Algorithm Development and Validation Study · December 2023
Articles
JMIR Cardio
The Montreal Model: An Integrative Biomedical-Psychedelic Approach to Ketamine for Severe Treatment-Resistant Depression · September 2023
Articles
Frontiers in Psychiatry
Successful Early Lamotrigine and Aripiprazole Augmentation of Clomipramine in Severe Obsessive-Compulsive Disorder · August 2023
Articles
Clinical Psychopharmacology and Neuroscience
Buprenorphine Deregulation as an Opioid Crisis Policy Response – A Comparative Analysis between France and the United States · August 2023
Articles
International Journal of Drug Policy
Psilocybin-Assisted Therapy for Depression: A Systematic Review and Dose-Response Meta-Analysis of Human Studies · August 2023
Articles
European Neuropsychopharmacology
Brexpiprazole versus Placebo or Other Antidepressive Agents for Treating Depression · July 2023
Abstracts
Cochrane Database of Systematic Reviews
Absolute and Relative Risks of Kidney Outcomes Associated with Lithium vs Valproate Use in Sweden · July 2023
Articles
JAMA Network Open
Biweekly vs Triweekly Low Dose Intravenous Ketamine Acute Series for Severe Major Depression: A Case Report · June 2023
Articles
Journal of Affective Disorders Reports
Sustaining the Benefits of Intravenous Ketamine with Behavioural Activation Therapy for Depression: A Case Series · June 2023
Articles
Journal of Affective Disorders Reports
Adverse Events with Quetiapine and Clarithromycin Coprescription: A Population-Based Retrospective Cohort Study · June 2023
Articles
Health Science Reports
Associations of Methadone and Buprenorphine-Naloxone Doses with Unregulated Opioid Use, Treatment Retention, and Adverse Events in Prescription-Type Opioid Use Disorders: Exploratory Analyses of the OPTIMA Study · June 2023
Articles
American Journal on Addictions
The Role of Ketamine in the Treatment of Bipolar Depression: A Scoping Review · June 2023
Articles
Brain Sciences
Neurobiological Correlates of Psilocybin Response in Depression · May 2023
Articles
Primary Care Companion for CNS Disorders
Infant Exposure to Fluvoxamine through Placenta and Human Milk: A Case Series – A Contribution from the ConcePTION Project · May 2023
Articles
Frontiers in Psychiatry
Real-World Effectiveness of Repeated Intravenous Ketamine Infusions for Treatment-Resistant Depression in Transitional Age Youth · May 2023
Articles
Journal of Psychopharmacology